Kamal Mostafa 4
4 · MAGELLAN HEALTH INC · Filed Mar 5, 2021
Insider Transaction Report
Form 4
Kamal Mostafa
CEO, Magellan Rx Management
Transactions
- Exercise/Conversion
Ordinary Common Stock, $0.01 par value
2021-03-04+6,242→ 9,066 total - Tax Payment
Ordinary Common Stock, $0.01 par value
2021-03-04$93.47/sh−3,072$287,140→ 5,994 total - Award
Restricted Stock Units
2021-03-03+25,439→ 25,439 totalExercise: $0.00→ Common Stock (25,439 underlying) - Exercise/Conversion
Restricted Stock Units
2021-03-04−6,242→ 12,482 totalExercise: $0.00→ Common Stock (6,242 underlying)
Footnotes (6)
- [F1]This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 4, 2020. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
- [F2]Not applicable.
- [F3]Represents the portion of shares withheld by the Company in order to pay taxes.
- [F4]Closing price on NASDAQ on March 4, 2021.
- [F5]Restricted Stock Units vest in one third increments on March 3rd of each of 2022, 2023 and 2024, subject to earlier acceleration or forfeiture.
- [F6]The remainder of 12,482 Restricted Stock Units shall vest in equal increments on March 4, 2022 and 2023, subject to earlier acceleration or forfeiture.